Seattle Genetics (SGEN) Q4 2020 Earnings Call Transcript
SGEN earnings call for the period ending December 31, 2020.
Seagen Inc.(SGEN)
Nasdaq Global Select
SGEN
$145.50
-$4.14
-2.8%
Price as of April 16, 2021, 8:00 p.m. EDT
View Interactive SGEN Charts
A biotechnology company that develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.
Interactive Chart
News & Analysis: Seagen Inc.
The Fool has written over 200 articles on Seagen Inc..
Here's Why Seagen Jumped Higher Today
The rumor mill took hold in late-day trading.
3 Top Growth Stocks to Buy on the Dip
All of these stocks are down more than 10% in the past four weeks.
Why Seagen Shares Are Tumbling 12.5% Today
A broad market sell-off is trumping third-quarter results that outpaced analyst expectations.
Seattle Genetics (SGEN) Q3 2020 Earnings Call Transcript
SGEN earnings call for the period ending September 30, 2020.
Why Seattle Genetics Stock Jumped 24% in September
Investors celebrated news of a big partnership -- and a big capital infusion.
Next Coronavirus Market Crash: Where to Invest $10,000
Prep your portfolio by buying shares of healthcare companies that can deliver revenue growth in the worst of times.
Merck Inks Multibillion-Dollar Deal With Seattle Genetics, Including Equity
Merck is acquiring $1 billion in Seattle Genetics shares as part of a wide-ranging collaboration agreement.
Seattle Genetics (SGEN) Q2 2020 Earnings Call Transcript
SGEN earnings call for the period ending June 30, 2020.
Why Seattle Genetics Shares Climbed 48.7% in the First Half
Two drug approvals in just a few months gave investors reason to cheer.
